Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/moneygram-names-luke-tuttle-as-chief-technology-officer/